首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Diazido Mixed-Amine Platinum(IV) Anticancer Complexes Activatable by Visible-Light Form Novel DNA Adducts
【2h】

Diazido Mixed-Amine Platinum(IV) Anticancer Complexes Activatable by Visible-Light Form Novel DNA Adducts

机译:Diazido混合胺铂(IV)抗癌复合物可被可见光形式的新型DNA加合物激活。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from problems of resistance and side-effects. Photoactivatable PtIV prodrugs offer the potential of targeted drug release and new mechanisms of action. We report the synthesis, X-ray crystallographic and spectroscopic properties of photoactivatable diazido complexes trans,trans,trans-[Pt(N3)2(OH)2(MA)(Py)] (>1; MA=methylamine, Py=pyridine) and trans,trans,trans-[Pt(N3)2(OH)2(MA)(Tz)] (>2; Tz=thiazole), and interpret their photophysical properties by TD-DFT modelling. The orientation of the azido groups is highly dependent on H bonding and crystal packing, as shown by polymorphs >1 p and >1 q. Complexes >1 and >2 are stable in the dark towards hydrolysis and glutathione reduction, but undergo rapid photoreduction with UVA or blue light with minimal amine photodissociation. They are over an order of magnitude more potent towards HaCaT keratinocytes, A2780 ovarian, and OE19 oesophageal carcinoma cells than cisplatin and show particular potency towards cisplatin-resistant human ovarian cancer cells (A2780cis). Analysis of binding to calf-thymus (CT), plasmids, oligonucleotide DNA and individual nucleotides reveals that photoactivated >1 and >2 form both mono- and bifunctional DNA lesions, with preference for G and C, similar to transplatin, but with significantly larger unwinding angles and a higher percentage of interstrand cross-links, with evidence for DNA strand cross-linking further supported by a comet assay. DNA lesions of >1 and >2 on a 50 bp duplex were not recognised by HMGB1 protein, in contrast to cisplatin-type lesions. The photo-induced platination reactions of DNA by >1 and >2 show similarities with the products of the dark reactions of the PtII compounds trans-[PtCl2(MA)(Py)] (>5) and trans-[PtCl2(MA)(Tz)] (>6). Following photoactivation, complex >2 reacted most rapidly with CT DNA, followed by >1, whereas the dark reactions of >5 and >6 with DNA were comparatively slow. Complexes >1 and >2 can therefore give rapid potent photocytotoxicity and novel DNA lesions in cancer cells, with no activity in the absence of irradiation.
机译:铂铂(m)ine络合物(例如顺铂)是成功的抗癌药物,但存在耐药性和副作用的问题。可光活化的Pt IV 前药具有靶向释放药物和新作用机制的潜力。我们报告了可光活化重氮叠氮化合物反式,反式,反式-[Pt(N3)2(OH)2(MA)(Py)](> 1 ; MA)的合成,X射线晶体学和光谱性质=甲胺,Py =吡啶)和反式,反式,反式-[Pt(N3)2(OH)2(MA)(Tz)](> 2 ; Tz =噻唑),并解释其光物理性质TD-DFT建模的特性。叠氮基的取向高度依赖于H键和晶体堆积,如多晶型> 1 p 和> 1 q 所示。配合物> 1 和> 2 在黑暗中对水解和谷胱甘肽还原都是稳定的,但是会通过UVA或蓝光进行快速光还原,而胺的光解离最小。它们对HaCaT角质形成细胞,A2780卵巢和OE19食管癌细胞的作用比顺铂强一个数量级,并且对顺铂耐药的人卵巢癌细胞(A2780cis)表现出特殊的作用。分析与小牛胸腺(CT),质粒,寡核苷酸DNA和单个核苷酸的结合后发现,光活化的> 1 和> 2 会形成单功能和双功能DNA损伤,优先考虑G和C与跨铂相似,但展开角度大得多,链间交联百分比更高,彗星试验进一步证明了DNA链交联的证据。与顺铂型病变相反,HMGB1蛋白无法识别50 bp双链体上的> 1 和> 2 的DNA病变。 > 1 和> 2 对DNA的光致平台反应与Pt II 化合物反式-[]的暗反应产物相似。 PtCl2(MA)(Py)](> 5 )和反式[PtCl2(MA)(Tz)](> 6 )。光激活后,复合物> 2 与CT DNA的反应最快,随后是> 1 ,而> 5 和> 6 的暗反应。与DNA比较弱。因此,复合物> 1 和> 2 可以在癌细胞中产生快速有效的光细胞毒性和新颖的DNA损伤,在没有照射的情况下没有活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号